California 2021-2022 Regular Session

California Assembly Bill AB607 Compare Versions

OldNewDifferences
1-Amended IN Assembly January 03, 2022 CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION Assembly Bill No. 607Introduced by Assembly Members Arambula and PattersonFebruary 12, 2021 An act to add and repeal Section 6364.7 of the Revenue and Taxation Code, relating to taxation, to take effect immediately, tax levy. LEGISLATIVE COUNSEL'S DIGESTAB 607, as amended, Arambula. Sales and use taxes: exemptions: blood screening testing.Existing state sales and use tax laws impose a tax on retailers measured by the gross receipts from the sale of tangible personal property sold at retail in this state or on the storage, use, or other consumption in this state of tangible personal property purchased from a retailer for storage, use, or other consumption in this state. The Sales and Use Tax Law provides various exemptions from those taxes, including an exemption for the sale of, or the storage, use, or consumption of, any container used to collect or store human whole blood, plasma, blood products, or blood derivatives.This bill, on and after January 1, 2022, 2023, and before January 1, 2027, 2028, would exempt the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, any reagents or chemicals, and lab equipment and supplies, used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.Existing law requires a bill that would authorize a new tax expenditure under the Sales and Use Tax Law to identify specific goals, purposes, and objectives that the tax expenditure will achieve, and detailed performance indicators and data collection requirements for determining whether the tax expenditure achieves these goals, purposes, and objectives.This bill would include additional information required for any bill authorizing a new tax expenditure. The Bradley-Burns Uniform Local Sales and Use Tax Law authorizes counties and cities to impose local sales and use taxes in conformity with the Sales and Use Tax Law, and existing laws authorize districts, as specified, to impose transactions and use taxes in accordance with the Transactions and Use Tax Law, which generally conforms to the Sales and Use Tax Law. Amendments to the Sales and Use Tax Law are automatically incorporated into the local tax laws.Existing law requires the state to reimburse counties and cities for revenue losses caused by the enactment of sales and use tax exemptions.This bill would provide that, notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made and the state shall not reimburse any local agencies for sales and use tax revenues lost by them pursuant to this bill. This bill would take effect immediately as a tax levy.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 6364.7 is added to the Revenue and Taxation Code, to read:6364.7. (a) On and after January 1, 2022, 2023, and before January 1, 2027, 2028, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both of the following:(1) Reagents or chemicals used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure ensure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered FDA-registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed nonhospital blood bank means any FDA-licensed or FDA-registered facility that is not a hospital and recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, 2028, and as of that date is repealed.SEC. 2. For purposes of complying with Section 41 of the Revenue and Taxation Code, with respect to the tax expenditure created by the addition of Section 6364.7 to the Revenue and Taxation Code made by this act, the Legislature finds and declares all of the following:(a) The specific goals, purposes, and objectives that this act will achieve are:(1) To provide a tax incentive for blood banks to test their own blood donations and to motivate testing facilities to locate in California.(2) To ensure that, in the event of a disaster or homeland security event, California is able to test blood donations without transferring many of those blood samples out of state for testing.(b) Detailed performance indicators for the Legislature to use in determining whether this act meets the goals, purposes, and objectives listed in subdivision (a) are:(1) The number of blood banks who initiate testing of blood donations in their own facilities.(2) Whether any new facilities are established in California to test blood donations.(c) The Central California Blood Center and the Stanford Blood Center shall annually provide to the California Department of Tax and Fee Administration the information described in subdivision (b) and shall report the information to the Legislature in any year in which Section 6364.7 of the Revenue and Taxation Code is operative.SEC. 3. Notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made by this act and the state shall not reimburse any local agency for any sales and use tax revenues lost by it under this act.SEC. 4. This act provides for a tax levy within the meaning of Article IV of the California Constitution and shall go into immediate effect.
1+CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION Assembly Bill No. 607Introduced by Assembly Members Arambula and PattersonFebruary 12, 2021 An act to add and repeal Section 6364.7 of the Revenue and Taxation Code, relating to taxation, to take effect immediately, tax levy. LEGISLATIVE COUNSEL'S DIGESTAB 607, as introduced, Arambula. Sales and use taxes: exemptions: blood screening testing.Existing state sales and use tax laws impose a tax on retailers measured by the gross receipts from the sale of tangible personal property sold at retail in this state or on the storage, use, or other consumption in this state of tangible personal property purchased from a retailer for storage, use, or other consumption in this state. The Sales and Use Tax Law provides various exemptions from those taxes, including an exemption for the sale of, or the storage, use, or consumption of, any container used to collect or store human whole blood, plasma, blood products, or blood derivatives.This bill, on and after January 1, 2022, and before January 1, 2027, would exempt the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, any reagents or chemicals, and lab equipment and supplies, used by a licensed blood bank to perform blood screening tests on donated human blood.Existing law requires a bill that would authorize a new tax expenditure under the Sales and Use Tax Law to identify specific goals, purposes, and objectives that the tax expenditure will achieve, and detailed performance indicators and data collection requirements for determining whether the tax expenditure achieves these goals, purposes, and objectives.This bill would include additional information required for any bill authorizing a new tax expenditure. The Bradley-Burns Uniform Local Sales and Use Tax Law authorizes counties and cities to impose local sales and use taxes in conformity with the Sales and Use Tax Law, and existing laws authorize districts, as specified, to impose transactions and use taxes in accordance with the Transactions and Use Tax Law, which generally conforms to the Sales and Use Tax Law. Amendments to the Sales and Use Tax Law are automatically incorporated into the local tax laws.Existing law requires the state to reimburse counties and cities for revenue losses caused by the enactment of sales and use tax exemptions.This bill would provide that, notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made and the state shall not reimburse any local agencies for sales and use tax revenues lost by them pursuant to this bill. This bill would take effect immediately as a tax levy.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO Bill TextThe people of the State of California do enact as follows:SECTION 1. Section 6364.7 is added to the Revenue and Taxation Code, to read:6364.7. (a) On and after January 1, 2022, and before January 1, 2027, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both the following:(1) Reagents or chemicals used by a licensed blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed blood bank means any FDA-licensed or FDA-registered facility that recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, and as of that date is repealed.SEC. 2. For purposes of complying with Section 41 of the Revenue and Taxation Code, with respect to the tax expenditure created by the addition of Section 6364.7 to the Revenue and Taxation Code made by this act, the Legislature finds and declares all of the following:(a) The specific goals, purposes, and objectives that this act will achieve are:(1) To provide a tax incentive for blood banks to test their own blood donations and to motivate testing facilities to locate in California.(2) To ensure that, in the event of a disaster or homeland security event, California is able to test blood donations without transferring many of those blood samples out of state for testing.(b) Detailed performance indicators for the Legislature to use in determining whether this act meets the goals, purposes, and objectives listed in subdivision (a) are:(1) The number of blood banks who initiate testing of blood donations in their own facilities.(2) Whether any new facilities are established in California to test blood donations.(c) The Central California Blood Center and the Stanford Blood Center shall annually provide to the California Department of Tax and Fee Administration the information described in subdivision (b) and shall report the information to the Legislature in any year in which Section 6364.7 of the Revenue and Taxation Code is operative.SEC. 3. Notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made by this act and the state shall not reimburse any local agency for any sales and use tax revenues lost by it under this act.SEC. 4. This act provides for a tax levy within the meaning of Article IV of the California Constitution and shall go into immediate effect.
22
3- Amended IN Assembly January 03, 2022 CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION Assembly Bill No. 607Introduced by Assembly Members Arambula and PattersonFebruary 12, 2021 An act to add and repeal Section 6364.7 of the Revenue and Taxation Code, relating to taxation, to take effect immediately, tax levy. LEGISLATIVE COUNSEL'S DIGESTAB 607, as amended, Arambula. Sales and use taxes: exemptions: blood screening testing.Existing state sales and use tax laws impose a tax on retailers measured by the gross receipts from the sale of tangible personal property sold at retail in this state or on the storage, use, or other consumption in this state of tangible personal property purchased from a retailer for storage, use, or other consumption in this state. The Sales and Use Tax Law provides various exemptions from those taxes, including an exemption for the sale of, or the storage, use, or consumption of, any container used to collect or store human whole blood, plasma, blood products, or blood derivatives.This bill, on and after January 1, 2022, 2023, and before January 1, 2027, 2028, would exempt the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, any reagents or chemicals, and lab equipment and supplies, used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.Existing law requires a bill that would authorize a new tax expenditure under the Sales and Use Tax Law to identify specific goals, purposes, and objectives that the tax expenditure will achieve, and detailed performance indicators and data collection requirements for determining whether the tax expenditure achieves these goals, purposes, and objectives.This bill would include additional information required for any bill authorizing a new tax expenditure. The Bradley-Burns Uniform Local Sales and Use Tax Law authorizes counties and cities to impose local sales and use taxes in conformity with the Sales and Use Tax Law, and existing laws authorize districts, as specified, to impose transactions and use taxes in accordance with the Transactions and Use Tax Law, which generally conforms to the Sales and Use Tax Law. Amendments to the Sales and Use Tax Law are automatically incorporated into the local tax laws.Existing law requires the state to reimburse counties and cities for revenue losses caused by the enactment of sales and use tax exemptions.This bill would provide that, notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made and the state shall not reimburse any local agencies for sales and use tax revenues lost by them pursuant to this bill. This bill would take effect immediately as a tax levy.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO
3+ CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION Assembly Bill No. 607Introduced by Assembly Members Arambula and PattersonFebruary 12, 2021 An act to add and repeal Section 6364.7 of the Revenue and Taxation Code, relating to taxation, to take effect immediately, tax levy. LEGISLATIVE COUNSEL'S DIGESTAB 607, as introduced, Arambula. Sales and use taxes: exemptions: blood screening testing.Existing state sales and use tax laws impose a tax on retailers measured by the gross receipts from the sale of tangible personal property sold at retail in this state or on the storage, use, or other consumption in this state of tangible personal property purchased from a retailer for storage, use, or other consumption in this state. The Sales and Use Tax Law provides various exemptions from those taxes, including an exemption for the sale of, or the storage, use, or consumption of, any container used to collect or store human whole blood, plasma, blood products, or blood derivatives.This bill, on and after January 1, 2022, and before January 1, 2027, would exempt the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, any reagents or chemicals, and lab equipment and supplies, used by a licensed blood bank to perform blood screening tests on donated human blood.Existing law requires a bill that would authorize a new tax expenditure under the Sales and Use Tax Law to identify specific goals, purposes, and objectives that the tax expenditure will achieve, and detailed performance indicators and data collection requirements for determining whether the tax expenditure achieves these goals, purposes, and objectives.This bill would include additional information required for any bill authorizing a new tax expenditure. The Bradley-Burns Uniform Local Sales and Use Tax Law authorizes counties and cities to impose local sales and use taxes in conformity with the Sales and Use Tax Law, and existing laws authorize districts, as specified, to impose transactions and use taxes in accordance with the Transactions and Use Tax Law, which generally conforms to the Sales and Use Tax Law. Amendments to the Sales and Use Tax Law are automatically incorporated into the local tax laws.Existing law requires the state to reimburse counties and cities for revenue losses caused by the enactment of sales and use tax exemptions.This bill would provide that, notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made and the state shall not reimburse any local agencies for sales and use tax revenues lost by them pursuant to this bill. This bill would take effect immediately as a tax levy.Digest Key Vote: MAJORITY Appropriation: NO Fiscal Committee: YES Local Program: NO
44
5- Amended IN Assembly January 03, 2022
65
7-Amended IN Assembly January 03, 2022
6+
7+
88
99 CALIFORNIA LEGISLATURE 20212022 REGULAR SESSION
1010
1111 Assembly Bill
1212
1313 No. 607
1414
1515 Introduced by Assembly Members Arambula and PattersonFebruary 12, 2021
1616
1717 Introduced by Assembly Members Arambula and Patterson
1818 February 12, 2021
1919
2020 An act to add and repeal Section 6364.7 of the Revenue and Taxation Code, relating to taxation, to take effect immediately, tax levy.
2121
2222 LEGISLATIVE COUNSEL'S DIGEST
2323
2424 ## LEGISLATIVE COUNSEL'S DIGEST
2525
26-AB 607, as amended, Arambula. Sales and use taxes: exemptions: blood screening testing.
26+AB 607, as introduced, Arambula. Sales and use taxes: exemptions: blood screening testing.
2727
28-Existing state sales and use tax laws impose a tax on retailers measured by the gross receipts from the sale of tangible personal property sold at retail in this state or on the storage, use, or other consumption in this state of tangible personal property purchased from a retailer for storage, use, or other consumption in this state. The Sales and Use Tax Law provides various exemptions from those taxes, including an exemption for the sale of, or the storage, use, or consumption of, any container used to collect or store human whole blood, plasma, blood products, or blood derivatives.This bill, on and after January 1, 2022, 2023, and before January 1, 2027, 2028, would exempt the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, any reagents or chemicals, and lab equipment and supplies, used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.Existing law requires a bill that would authorize a new tax expenditure under the Sales and Use Tax Law to identify specific goals, purposes, and objectives that the tax expenditure will achieve, and detailed performance indicators and data collection requirements for determining whether the tax expenditure achieves these goals, purposes, and objectives.This bill would include additional information required for any bill authorizing a new tax expenditure. The Bradley-Burns Uniform Local Sales and Use Tax Law authorizes counties and cities to impose local sales and use taxes in conformity with the Sales and Use Tax Law, and existing laws authorize districts, as specified, to impose transactions and use taxes in accordance with the Transactions and Use Tax Law, which generally conforms to the Sales and Use Tax Law. Amendments to the Sales and Use Tax Law are automatically incorporated into the local tax laws.Existing law requires the state to reimburse counties and cities for revenue losses caused by the enactment of sales and use tax exemptions.This bill would provide that, notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made and the state shall not reimburse any local agencies for sales and use tax revenues lost by them pursuant to this bill. This bill would take effect immediately as a tax levy.
28+Existing state sales and use tax laws impose a tax on retailers measured by the gross receipts from the sale of tangible personal property sold at retail in this state or on the storage, use, or other consumption in this state of tangible personal property purchased from a retailer for storage, use, or other consumption in this state. The Sales and Use Tax Law provides various exemptions from those taxes, including an exemption for the sale of, or the storage, use, or consumption of, any container used to collect or store human whole blood, plasma, blood products, or blood derivatives.This bill, on and after January 1, 2022, and before January 1, 2027, would exempt the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, any reagents or chemicals, and lab equipment and supplies, used by a licensed blood bank to perform blood screening tests on donated human blood.Existing law requires a bill that would authorize a new tax expenditure under the Sales and Use Tax Law to identify specific goals, purposes, and objectives that the tax expenditure will achieve, and detailed performance indicators and data collection requirements for determining whether the tax expenditure achieves these goals, purposes, and objectives.This bill would include additional information required for any bill authorizing a new tax expenditure. The Bradley-Burns Uniform Local Sales and Use Tax Law authorizes counties and cities to impose local sales and use taxes in conformity with the Sales and Use Tax Law, and existing laws authorize districts, as specified, to impose transactions and use taxes in accordance with the Transactions and Use Tax Law, which generally conforms to the Sales and Use Tax Law. Amendments to the Sales and Use Tax Law are automatically incorporated into the local tax laws.Existing law requires the state to reimburse counties and cities for revenue losses caused by the enactment of sales and use tax exemptions.This bill would provide that, notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made and the state shall not reimburse any local agencies for sales and use tax revenues lost by them pursuant to this bill. This bill would take effect immediately as a tax levy.
2929
3030 Existing state sales and use tax laws impose a tax on retailers measured by the gross receipts from the sale of tangible personal property sold at retail in this state or on the storage, use, or other consumption in this state of tangible personal property purchased from a retailer for storage, use, or other consumption in this state. The Sales and Use Tax Law provides various exemptions from those taxes, including an exemption for the sale of, or the storage, use, or consumption of, any container used to collect or store human whole blood, plasma, blood products, or blood derivatives.
3131
32-This bill, on and after January 1, 2022, 2023, and before January 1, 2027, 2028, would exempt the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, any reagents or chemicals, and lab equipment and supplies, used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.
32+This bill, on and after January 1, 2022, and before January 1, 2027, would exempt the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, any reagents or chemicals, and lab equipment and supplies, used by a licensed blood bank to perform blood screening tests on donated human blood.
3333
3434 Existing law requires a bill that would authorize a new tax expenditure under the Sales and Use Tax Law to identify specific goals, purposes, and objectives that the tax expenditure will achieve, and detailed performance indicators and data collection requirements for determining whether the tax expenditure achieves these goals, purposes, and objectives.
3535
3636 This bill would include additional information required for any bill authorizing a new tax expenditure.
3737
3838 The Bradley-Burns Uniform Local Sales and Use Tax Law authorizes counties and cities to impose local sales and use taxes in conformity with the Sales and Use Tax Law, and existing laws authorize districts, as specified, to impose transactions and use taxes in accordance with the Transactions and Use Tax Law, which generally conforms to the Sales and Use Tax Law. Amendments to the Sales and Use Tax Law are automatically incorporated into the local tax laws.
3939
4040 Existing law requires the state to reimburse counties and cities for revenue losses caused by the enactment of sales and use tax exemptions.
4141
4242 This bill would provide that, notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made and the state shall not reimburse any local agencies for sales and use tax revenues lost by them pursuant to this bill.
4343
4444 This bill would take effect immediately as a tax levy.
4545
4646 ## Digest Key
4747
4848 ## Bill Text
4949
50-The people of the State of California do enact as follows:SECTION 1. Section 6364.7 is added to the Revenue and Taxation Code, to read:6364.7. (a) On and after January 1, 2022, 2023, and before January 1, 2027, 2028, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both of the following:(1) Reagents or chemicals used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure ensure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered FDA-registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed nonhospital blood bank means any FDA-licensed or FDA-registered facility that is not a hospital and recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, 2028, and as of that date is repealed.SEC. 2. For purposes of complying with Section 41 of the Revenue and Taxation Code, with respect to the tax expenditure created by the addition of Section 6364.7 to the Revenue and Taxation Code made by this act, the Legislature finds and declares all of the following:(a) The specific goals, purposes, and objectives that this act will achieve are:(1) To provide a tax incentive for blood banks to test their own blood donations and to motivate testing facilities to locate in California.(2) To ensure that, in the event of a disaster or homeland security event, California is able to test blood donations without transferring many of those blood samples out of state for testing.(b) Detailed performance indicators for the Legislature to use in determining whether this act meets the goals, purposes, and objectives listed in subdivision (a) are:(1) The number of blood banks who initiate testing of blood donations in their own facilities.(2) Whether any new facilities are established in California to test blood donations.(c) The Central California Blood Center and the Stanford Blood Center shall annually provide to the California Department of Tax and Fee Administration the information described in subdivision (b) and shall report the information to the Legislature in any year in which Section 6364.7 of the Revenue and Taxation Code is operative.SEC. 3. Notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made by this act and the state shall not reimburse any local agency for any sales and use tax revenues lost by it under this act.SEC. 4. This act provides for a tax levy within the meaning of Article IV of the California Constitution and shall go into immediate effect.
50+The people of the State of California do enact as follows:SECTION 1. Section 6364.7 is added to the Revenue and Taxation Code, to read:6364.7. (a) On and after January 1, 2022, and before January 1, 2027, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both the following:(1) Reagents or chemicals used by a licensed blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed blood bank means any FDA-licensed or FDA-registered facility that recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, and as of that date is repealed.SEC. 2. For purposes of complying with Section 41 of the Revenue and Taxation Code, with respect to the tax expenditure created by the addition of Section 6364.7 to the Revenue and Taxation Code made by this act, the Legislature finds and declares all of the following:(a) The specific goals, purposes, and objectives that this act will achieve are:(1) To provide a tax incentive for blood banks to test their own blood donations and to motivate testing facilities to locate in California.(2) To ensure that, in the event of a disaster or homeland security event, California is able to test blood donations without transferring many of those blood samples out of state for testing.(b) Detailed performance indicators for the Legislature to use in determining whether this act meets the goals, purposes, and objectives listed in subdivision (a) are:(1) The number of blood banks who initiate testing of blood donations in their own facilities.(2) Whether any new facilities are established in California to test blood donations.(c) The Central California Blood Center and the Stanford Blood Center shall annually provide to the California Department of Tax and Fee Administration the information described in subdivision (b) and shall report the information to the Legislature in any year in which Section 6364.7 of the Revenue and Taxation Code is operative.SEC. 3. Notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made by this act and the state shall not reimburse any local agency for any sales and use tax revenues lost by it under this act.SEC. 4. This act provides for a tax levy within the meaning of Article IV of the California Constitution and shall go into immediate effect.
5151
5252 The people of the State of California do enact as follows:
5353
5454 ## The people of the State of California do enact as follows:
5555
56-SECTION 1. Section 6364.7 is added to the Revenue and Taxation Code, to read:6364.7. (a) On and after January 1, 2022, 2023, and before January 1, 2027, 2028, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both of the following:(1) Reagents or chemicals used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure ensure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered FDA-registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed nonhospital blood bank means any FDA-licensed or FDA-registered facility that is not a hospital and recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, 2028, and as of that date is repealed.
56+SECTION 1. Section 6364.7 is added to the Revenue and Taxation Code, to read:6364.7. (a) On and after January 1, 2022, and before January 1, 2027, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both the following:(1) Reagents or chemicals used by a licensed blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed blood bank means any FDA-licensed or FDA-registered facility that recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, and as of that date is repealed.
5757
5858 SECTION 1. Section 6364.7 is added to the Revenue and Taxation Code, to read:
5959
6060 ### SECTION 1.
6161
62-6364.7. (a) On and after January 1, 2022, 2023, and before January 1, 2027, 2028, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both of the following:(1) Reagents or chemicals used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure ensure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered FDA-registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed nonhospital blood bank means any FDA-licensed or FDA-registered facility that is not a hospital and recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, 2028, and as of that date is repealed.
62+6364.7. (a) On and after January 1, 2022, and before January 1, 2027, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both the following:(1) Reagents or chemicals used by a licensed blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed blood bank means any FDA-licensed or FDA-registered facility that recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, and as of that date is repealed.
6363
64-6364.7. (a) On and after January 1, 2022, 2023, and before January 1, 2027, 2028, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both of the following:(1) Reagents or chemicals used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure ensure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered FDA-registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed nonhospital blood bank means any FDA-licensed or FDA-registered facility that is not a hospital and recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, 2028, and as of that date is repealed.
64+6364.7. (a) On and after January 1, 2022, and before January 1, 2027, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both the following:(1) Reagents or chemicals used by a licensed blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed blood bank means any FDA-licensed or FDA-registered facility that recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, and as of that date is repealed.
6565
66-6364.7. (a) On and after January 1, 2022, 2023, and before January 1, 2027, 2028, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both of the following:(1) Reagents or chemicals used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure ensure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered FDA-registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed nonhospital blood bank means any FDA-licensed or FDA-registered facility that is not a hospital and recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, 2028, and as of that date is repealed.
66+6364.7. (a) On and after January 1, 2022, and before January 1, 2027, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both the following:(1) Reagents or chemicals used by a licensed blood bank to perform blood screening tests on donated human blood.(2) Lab equipment and supplies used by a licensed blood bank to perform blood screening tests on donated human blood.(b) For purposes of this section:(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.(2) Donated human blood means human blood that is given to an FDA-licensed or registered blood facility, by a medically eligible individual, after being properly consented.(3) FDA means the United States Food and Drug Administration.(4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.(5) Licensed blood bank means any FDA-licensed or FDA-registered facility that recruits, collects, processes, and distributes human blood for transfusion purposes.(6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.(c) This section shall remain in effect only until December 31, 2027, and as of that date is repealed.
6767
6868
6969
70-6364.7. (a) On and after January 1, 2022, 2023, and before January 1, 2027, 2028, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both of the following:
70+6364.7. (a) On and after January 1, 2022, and before January 1, 2027, there are exempted from the taxes imposed by this part the gross receipts from the sale in this state of, and the storage, use, or other consumption in this state of, both the following:
7171
72-(1) Reagents or chemicals used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.
72+(1) Reagents or chemicals used by a licensed blood bank to perform blood screening tests on donated human blood.
7373
74-(2) Lab equipment and supplies used by a licensed nonhospital blood bank to perform blood screening tests on donated human blood.
74+(2) Lab equipment and supplies used by a licensed blood bank to perform blood screening tests on donated human blood.
7575
7676 (b) For purposes of this section:
7777
78-(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure ensure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.
78+(1) Blood screening tests means screening tests mandated by the FDA or the State of California to assure the safety of voluntary blood, platelets, and plasma donations, including, but not limited to, tests for basic red blood cell-type antigens (ABO), basic red blood cell antigens (Rh), antibodies, syphilis, hepatitis B and C, human immunodeficiency virus (HIV), human T-cell leukemia virus (HTLV), Chagas disease, West Nile virus, Zika virus, and any future-required donor screening test by whatever is the currently required methodology.
7979
80-(2) Donated human blood means human blood that is given to an FDA-licensed or registered FDA-registered blood facility, by a medically eligible individual, after being properly consented.
80+(2) Donated human blood means human blood that is given to an FDA-licensed or registered blood facility, by a medically eligible individual, after being properly consented.
8181
8282 (3) FDA means the United States Food and Drug Administration.
8383
8484 (4) Lab equipment and supplies mean any FDA-approved instruments, devices, and related data processing devices that are specifically required in order to perform blood screening tests.
8585
86-(5) Licensed nonhospital blood bank means any FDA-licensed or FDA-registered facility that is not a hospital and recruits, collects, processes, and distributes human blood for transfusion purposes.
86+(5) Licensed blood bank means any FDA-licensed or FDA-registered facility that recruits, collects, processes, and distributes human blood for transfusion purposes.
8787
8888 (6) Reagents or chemicals means only those reagents, quality control materials, assay kits, diluents, and calibrators that are specifically required in order to perform blood screening tests.
8989
90-(c) This section shall remain in effect only until December 31, 2027, 2028, and as of that date is repealed.
90+(c) This section shall remain in effect only until December 31, 2027, and as of that date is repealed.
9191
9292 SEC. 2. For purposes of complying with Section 41 of the Revenue and Taxation Code, with respect to the tax expenditure created by the addition of Section 6364.7 to the Revenue and Taxation Code made by this act, the Legislature finds and declares all of the following:(a) The specific goals, purposes, and objectives that this act will achieve are:(1) To provide a tax incentive for blood banks to test their own blood donations and to motivate testing facilities to locate in California.(2) To ensure that, in the event of a disaster or homeland security event, California is able to test blood donations without transferring many of those blood samples out of state for testing.(b) Detailed performance indicators for the Legislature to use in determining whether this act meets the goals, purposes, and objectives listed in subdivision (a) are:(1) The number of blood banks who initiate testing of blood donations in their own facilities.(2) Whether any new facilities are established in California to test blood donations.(c) The Central California Blood Center and the Stanford Blood Center shall annually provide to the California Department of Tax and Fee Administration the information described in subdivision (b) and shall report the information to the Legislature in any year in which Section 6364.7 of the Revenue and Taxation Code is operative.
9393
9494 SEC. 2. For purposes of complying with Section 41 of the Revenue and Taxation Code, with respect to the tax expenditure created by the addition of Section 6364.7 to the Revenue and Taxation Code made by this act, the Legislature finds and declares all of the following:(a) The specific goals, purposes, and objectives that this act will achieve are:(1) To provide a tax incentive for blood banks to test their own blood donations and to motivate testing facilities to locate in California.(2) To ensure that, in the event of a disaster or homeland security event, California is able to test blood donations without transferring many of those blood samples out of state for testing.(b) Detailed performance indicators for the Legislature to use in determining whether this act meets the goals, purposes, and objectives listed in subdivision (a) are:(1) The number of blood banks who initiate testing of blood donations in their own facilities.(2) Whether any new facilities are established in California to test blood donations.(c) The Central California Blood Center and the Stanford Blood Center shall annually provide to the California Department of Tax and Fee Administration the information described in subdivision (b) and shall report the information to the Legislature in any year in which Section 6364.7 of the Revenue and Taxation Code is operative.
9595
9696 SEC. 2. For purposes of complying with Section 41 of the Revenue and Taxation Code, with respect to the tax expenditure created by the addition of Section 6364.7 to the Revenue and Taxation Code made by this act, the Legislature finds and declares all of the following:
9797
9898 ### SEC. 2.
9999
100100 (a) The specific goals, purposes, and objectives that this act will achieve are:
101101
102102 (1) To provide a tax incentive for blood banks to test their own blood donations and to motivate testing facilities to locate in California.
103103
104104 (2) To ensure that, in the event of a disaster or homeland security event, California is able to test blood donations without transferring many of those blood samples out of state for testing.
105105
106106 (b) Detailed performance indicators for the Legislature to use in determining whether this act meets the goals, purposes, and objectives listed in subdivision (a) are:
107107
108108 (1) The number of blood banks who initiate testing of blood donations in their own facilities.
109109
110110 (2) Whether any new facilities are established in California to test blood donations.
111111
112112 (c) The Central California Blood Center and the Stanford Blood Center shall annually provide to the California Department of Tax and Fee Administration the information described in subdivision (b) and shall report the information to the Legislature in any year in which Section 6364.7 of the Revenue and Taxation Code is operative.
113113
114114 SEC. 3. Notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made by this act and the state shall not reimburse any local agency for any sales and use tax revenues lost by it under this act.
115115
116116 SEC. 3. Notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made by this act and the state shall not reimburse any local agency for any sales and use tax revenues lost by it under this act.
117117
118118 SEC. 3. Notwithstanding Section 2230 of the Revenue and Taxation Code, no appropriation is made by this act and the state shall not reimburse any local agency for any sales and use tax revenues lost by it under this act.
119119
120120 ### SEC. 3.
121121
122122 SEC. 4. This act provides for a tax levy within the meaning of Article IV of the California Constitution and shall go into immediate effect.
123123
124124 SEC. 4. This act provides for a tax levy within the meaning of Article IV of the California Constitution and shall go into immediate effect.
125125
126126 SEC. 4. This act provides for a tax levy within the meaning of Article IV of the California Constitution and shall go into immediate effect.
127127
128128 ### SEC. 4.